By proceeding, you agree to our Terms of Use and Privacy Policy.
Revolo Biotherapeutics is developing revolutionary therapies powered to reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic diseases.
17-19 May 2022
Turbocharge the Development of Best-In-Class Treg-Directed Therapies, Maximizing Stability and Function to Deliver Safe, Scalable and Efficacious Therapies Globally As Biopharma turn their focus to autoimmune drug development, there has been an explo
Event Ended
USA
Paid
Boston
30-01 June 2023
Join us at the 5th Treg Summit, where we will be discussing the latest advancements in IL-2 and CAR-Treg therapies, and how advanced engineering and product design can enhance their tissue specificity, durability, stability, and safety, thus accelera